Modalis Therapeutics Corp Ordinary Shares 4883
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4883 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- JPY 77.00
- Day Range
- JPY 77.00–79.00
- 52-Week Range
- JPY 77.00–336.00
- Bid/Ask
- JPY 77.00 / JPY 78.00
- Market Cap
- JPY 2.60 Bil
- Volume/Avg
- 147,800 / 512,674
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.modalistx.com
Comparables
Valuation
|
Metric
|
4883
|
4563
|
4893
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 1.86 | 0.37 | 1.32 |
Price/Sales | — | 60.63 | 22.64 |
Price/Cash Flow | — | — | — |
Price/Earnings
4883
4563
4893
Financial Strength
|
Metric
|
4883
|
4563
|
4893
|
|---|---|---|---|
Quick Ratio | 9.51 | 1.68 | 65.18 |
Current Ratio | 9.88 | 2.38 | 66.28 |
Interest Coverage | −540.60 | — | — |
Quick Ratio
4883
4563
4893
Profitability
|
Metric
|
4883
|
4563
|
4893
|
|---|---|---|---|
Return on Assets (Normalized) | −89.83% | −16.00% | −19.85% |
Return on Equity (Normalized) | −102.37% | −19.90% | −20.61% |
Return on Invested Capital (Normalized) | −98.68% | −19.26% | −20.61% |
Return on Assets
4883
4563
4893
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rrbsgxcw | Rwhm | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Wymtqwly | Ljldv | $70.8 Bil | |
HLN
| Haleon PLC ADR | Ywgkqfdb | Rpbh | $38.2 Bil | |
VTRS
| Viatris Inc | Ksckbbvy | Clbx | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kgnzlywl | Ctqdy | $12.5 Bil | |
CTLT
| Catalent Inc | Jxxlfhj | Wrglzr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jnkydds | Xywg | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Qcqfgtvl | Ryhbm | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qnxsxqqn | Vnvsyw | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Mgyknblt | Kydm | $2.9 Bil |